COAGULATION DISORDER
Clinical trials for COAGULATION DISORDER explained in plain language.
Never miss a new study
Get alerted when new COAGULATION DISORDER trials appear
Sign up with your email to follow new studies for COAGULATION DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New reversal agent aims to stop bleeding in emergency surgeries
Disease control Recruiting nowThis study tests a new drug called TAK-330 to reverse the effects of blood thinners (Factor Xa inhibitors) in people who need urgent surgery. About 328 adults on these blood thinners will be randomly assigned to get TAK-330 or standard reversal treatment before their procedure. T…
Matched conditions: COAGULATION DISORDER
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Massive study aims to find safe drug doses for kids
Knowledge-focused Recruiting nowThis study looks at how certain medicines act in the bodies of children and young adults under 21. Researchers want to find the safest and most effective doses for these age groups. Participants are already taking these drugs as part of their regular care, or have had a recent CO…
Matched conditions: COAGULATION DISORDER
Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 07, 2026 18:43 UTC